New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...